X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8779) 8779
Publication (659) 659
Book / eBook (213) 213
Book Review (122) 122
Book Chapter (54) 54
Conference Proceeding (17) 17
Magazine Article (9) 9
Dissertation (4) 4
Newsletter (2) 2
Government Document (1) 1
Reference (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (7336) 7336
female (4639) 4639
male (4341) 4341
index medicus (4192) 4192
hematology (3544) 3544
adult (3409) 3409
middle aged (3334) 3334
oncology (3320) 3320
aged (2438) 2438
transplantation (1948) 1948
animals (1724) 1724
cancer (1639) 1639
hematologic neoplasms - therapy (1585) 1585
treatment outcome (1529) 1529
adolescent (1527) 1527
hematologic diseases - chemically induced (1440) 1440
hematologic malignancies (1432) 1432
immunology (1376) 1376
chemotherapy (1315) 1315
leukemia (1276) 1276
bone-marrow-transplantation (1172) 1172
child (1038) 1038
hematopoietic stem cells (1006) 1006
retrospective studies (974) 974
stem cells (956) 956
care and treatment (955) 955
antineoplastic combined chemotherapy protocols - therapeutic use (929) 929
transplantation, homologous (919) 919
health aspects (844) 844
hematopoietic stem cell transplantation (841) 841
therapy (839) 839
risk factors (828) 828
hematologic neoplasms - drug therapy (815) 815
acute myeloid-leukemia (809) 809
hematologic tests (785) 785
research (763) 763
young adult (763) 763
toxicity (754) 754
pharmacology & pharmacy (750) 750
versus-host-disease (742) 742
analysis (732) 732
hematology, oncology and palliative medicine (727) 727
stem-cell transplantation (709) 709
antineoplastic agents - therapeutic use (706) 706
child, preschool (702) 702
antineoplastic combined chemotherapy protocols - adverse effects (691) 691
dose-response relationship, drug (633) 633
hematopoietic stem cell transplantation - adverse effects (627) 627
survival analysis (618) 618
transplantation conditioning - methods (614) 614
disease-free survival (579) 579
hematopoietic stem cell transplantation - methods (578) 578
blood (573) 573
mortality (570) 570
medicine & public health (568) 568
bone marrow (563) 563
aged, 80 and over (551) 551
survival rate (549) 549
mice (548) 548
hematologic neoplasms - complications (547) 547
prognosis (529) 529
medicine (513) 513
follow-up studies (510) 510
antineoplastic agents - adverse effects (503) 503
hematologic neoplasms - mortality (503) 503
infant (500) 500
time factors (494) 494
drug administration schedule (476) 476
rats (467) 467
prospective studies (466) 466
survival (463) 463
lymphoma (456) 456
toxicology (456) 456
article (454) 454
acute lymphoblastic-leukemia (449) 449
graft vs host disease - prevention & control (448) 448
children (438) 438
research article (416) 416
lymphomas (411) 411
recurrence (394) 394
hematologic neoplasms - pathology (383) 383
apoptosis (377) 377
stem cell transplantation (374) 374
hematologic diseases - therapy (370) 370
combined modality therapy (366) 366
clinical trials as topic (365) 365
diagnosis (363) 363
patients (357) 357
drug therapy (355) 355
medical research (355) 355
immunotherapy (352) 352
cyclophosphamide (347) 347
non-hodgkins-lymphoma (347) 347
hematologic neoplasms - immunology (342) 342
transplantation conditioning (342) 342
graft vs host disease - etiology (340) 340
pediatrics (338) 338
science (335) 335
pharmacokinetics (332) 332
chronic lymphocytic-leukemia (331) 331
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (171) 171
Collection Dvlpm't (Acquisitions) - Closed Orders (13) 13
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (7) 7
Online Resources - Online (4) 4
St. Michael's Hospital - Stacks (2) 2
Toronto East General Hospital - Stacks (2) 2
UTL at Downsview - May be requested (2) 2
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Credit Valley Hospital - Stacks (1) 1
Humber River Regional Hospital - Church Stacks (1) 1
Markham Stouffville Hospital - Stacks (1) 1
Mt Sinai Hospital - Online (1) 1
Providence Healthcare - Stacks (1) 1
Robarts - Stacks (1) 1
Scarborough Hospital - Birchmount (1) 1
St. Michael's Hospital - Reference (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Reference (1) 1
UofT at Mississauga - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
Women's College Hospital - Reference (1) 1
Women's College Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (8748) 8748
Japanese (108) 108
French (65) 65
Russian (36) 36
Spanish (24) 24
German (20) 20
Chinese (14) 14
Polish (14) 14
Italian (9) 9
Portuguese (8) 8
Czech (7) 7
Hungarian (4) 4
Korean (2) 2
Arabic (1) 1
Hebrew (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 05/2008, Volume 26, Issue 13, pp. 2124 - 2130
Purpose Despite the fact that most gastroenteropancreatic neuroendocrine tumors (GEPNETs) are slow-growing, median overall survival ( OS) in patients with... 
LIVER METASTASES | STREPTOZOCIN | CHEMOEMBOLIZATION | SOUTHWEST-ONCOLOGY-GROUP | ONCOLOGY | CARCINOID-TUMORS | RADIONUCLIDE THERAPY | ENDOCRINE TUMORS | PHASE-II | METASTATIC NEUROENDOCRINE TUMORS | EPIDEMIOLOGY | Gastrointestinal Neoplasms - mortality | Humans | Middle Aged | Male | Gastrointestinal Neoplasms - pathology | Time Factors | Myelodysplastic Syndromes - chemically induced | Neuroendocrine Tumors - diagnostic imaging | Aged, 80 and over | Organometallic Compounds - therapeutic use | Adult | Female | Pancreatic Neoplasms - mortality | Neuroendocrine Tumors - pathology | Severity of Illness Index | Hematologic Diseases - chemically induced | Octreotide - analogs & derivatives | Risk Assessment | Organometallic Compounds - adverse effects | Pancreatic Neoplasms - pathology | Proportional Hazards Models | Carcinoid Tumor - diagnostic imaging | Octreotide - adverse effects | Logistic Models | Treatment Outcome | Octreotide - therapeutic use | Carcinoid Tumor - pathology | Disease-Free Survival | Gastrointestinal Neoplasms - diagnostic imaging | Neuroendocrine Tumors - mortality | Radionuclide Imaging | Aged | Chemical and Drug Induced Liver Injury | Radiopharmaceuticals - adverse effects | Carcinoid Tumor - mortality | Pancreatic Neoplasms - diagnostic imaging | Radiopharmaceuticals - therapeutic use | Index Medicus
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2016, Volume 96, Issue 1, pp. 228 - 239
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 01/2018, Volume 24, Issue 1, pp. 133 - 141
Journal Article
Journal Article
International Journal of Cancer, ISSN 0020-7136, 03/2018, Volume 142, Issue 6, pp. 1218 - 1229
Platinum‐based chemotherapy (PBC) in combination with the 3rd generation drugs is the first‐line treatment for patients with advanced non‐small cell lung... 
platinum‐based chemotherapy | grade 3/4 toxicity | non‐small cell lung cancer | regulatory single nucleotide polymorphism | nucleotide excision repair pathway | non-small cell lung cancer | platinum-based chemotherapy | SURVIVAL | CHEMOTHERAPY | NUCLEOTIDE EXCISION-REPAIR | POLYMORPHISMS | CISPLATIN | ONCOLOGY | RESISTANCE | ASSOCIATION | Lung Neoplasms - drug therapy | DNA Adducts - drug effects | Gastrointestinal Diseases - epidemiology | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | DNA Repair - genetics | RNA, Messenger - metabolism | DNA-Binding Proteins - metabolism | Young Adult | Aged, 80 and over | Biomarkers, Tumor - metabolism | Adult | Female | Hematologic Diseases - epidemiology | Lung Neoplasms - genetics | Hematologic Diseases - chemically induced | Carcinoma, Non-Small-Cell Lung - genetics | Computational Biology | DNA-Binding Proteins - genetics | Gastrointestinal Diseases - genetics | Hematologic Diseases - genetics | Aged | Biomarkers, Tumor - genetics | Polymorphism, Single Nucleotide | Carcinoma, Non-Small-Cell Lung - drug therapy | Gastrointestinal Diseases - chemically induced | Organoplatinum Compounds - adverse effects | Medical research | RNA | Lung cancer, Small cell | Lung cancer, Non-small cell | DNA repair | Quantitative genetics | Chemotherapy | Analysis | Medicine, Experimental | Genetic research | Single nucleotide polymorphisms | Chromosomes | Cancer | Drugs | Toxicity | Genes | Lung cancer | Single-nucleotide polymorphism | Drug development | Cancer therapies | Confidence intervals | Platinum | Repair | Deoxyribonucleic acid--DNA | Adducts | Non-small cell lung carcinoma | Nucleotide excision repair | Data processing | Gene expression | Patients | Quantitative trait loci | Molecular modelling | Predictions | Biomarkers | DNA adducts | Index Medicus
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2016, Volume 23, Issue 3, pp. 445 - 451
Journal Article
PLoS ONE, ISSN 1932-6203, 01/2014, Volume 9, Issue 1, p. e82681
Journal Article
Journal Article